| 000 | 01286 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250511131509.0 | ||
| 264 | 0 | _c19800124 | |
| 008 | 198001s 0 0 ger d | ||
| 022 | _a0025-8458 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHeilmann, E | |
| 245 | 0 | 0 |
_a[Drug-induced megaloblastic anemia]. _h[electronic resource] |
| 260 |
_bMedizinische Klinik _cAug 1979 |
||
| 300 |
_a1207-16 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAlcoholism _xcomplications |
| 650 | 0 | 4 |
_aAnemia, Macrocytic _xchemically induced |
| 650 | 0 | 4 |
_aAnemia, Megaloblastic _xchemically induced |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadverse effects |
| 650 | 0 | 4 |
_aAnticonvulsants _xadverse effects |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadverse effects |
| 650 | 0 | 4 |
_aContraceptives, Oral _xadverse effects |
| 650 | 0 | 4 | _aDrug-Related Side Effects and Adverse Reactions |
| 650 | 0 | 4 |
_aFolic Acid Antagonists _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMalabsorption Syndromes _xchemically induced |
| 650 | 0 | 4 |
_aPyrimethamine _xadverse effects |
| 650 | 0 | 4 |
_aTriamterene _xadverse effects |
| 650 | 0 | 4 |
_aTrimethoprim _xadverse effects |
| 650 | 0 | 4 |
_aVitamin B 12 _xmetabolism |
| 773 | 0 |
_tMedizinische Klinik _gvol. 74 _gno. 34 _gp. 1207-16 |
|
| 999 |
_c409180 _d409180 |
||